Skip to main content
Jim Hu, MD, Urology, New York, NY

JimCHuMDMPH

Urology New York, NY

Minimally Invasive Surgery, Surgical Oncology

Ronald Lynch Professor of Urology, Weill Cornell Medical College

Overview of Dr. Hu

Dr. Jim Hu is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Baylor College of Medicine and has been in practice 19 years. Dr. Hu accepts several types of health insurance, listed below. He is one of 189 doctors at New York-Presbyterian Hospital and one of 62 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Urology. He also speaks multiple languages, including Chinese (Mandarin). He has more than 100 publications and over 500 citings.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1998 - 2004
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2000 - Present
  • NY State Medical License
    NY State Medical License 2014 - 2026
  • MA State Medical License
    MA State Medical License 2005 - 2012
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Reconsidering the Trade-Offs of Prostate Cancer Screening  
    Jonathan E Shoag, Jim C Hu, The New England Journal of Medicine
  • Corrigendum Re: “The Impact of Prostate Size, Median Lobe, and Prior Benign Prostatic Hyperplasia Intervention on Robot-Assisted Laparoscopic Prostatectomy: Technique ...  
    Keith J Kowalczyk, Hua-Yin Yu, Jim C Hu, European Urology
  • Multi-Institutional Experience with Robotic Nephrectomy with Inferior Vena Cava Tumor Thrombectomy  
    Mani Menon, Ahmad Shabsigh, Daniel Eun, Craig Rogers, Monish Aron, Erik Castle, Mohamad Allaf, Chandru P Sundaram, Ronney Abaza, Jim C Hu, The Journal of Urology

Authored Content

  • Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the USAugust 2020
  • Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the USAugust 2020
  • Reconsidering the Trade-Offs of Prostate Cancer ScreeningJune 2020
  • Minerva Urologica E Nefrologica 2017 August;69(4):313-23August 2018
  • Join now to see all

Press Mentions

  • Study: Transperineal Prostate Biopsy Is the Better Option
    Study: Transperineal Prostate Biopsy Is the Better OptionOctober 8th, 2024
  • No Infections Seen After Transperineal Biopsy for Prostate Cancer
    No Infections Seen After Transperineal Biopsy for Prostate CancerOctober 1st, 2024
  • New Prostate Biopsy Technique Lowers Infection Risk
    New Prostate Biopsy Technique Lowers Infection RiskSeptember 19th, 2024
  • Join now to see all

Other Languages

  • Chinese (Mandarin)

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    Great West PPO
    Harvard Pilgrim HMO
    Health Net California Large Group PPO
    Health Net HMO - Employer Group
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PHCS PPO - Kaiser
    Multiplan PPO
    UniCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment